| First Author | Raveney BJ | Year | 2010 |
| Journal | Immunology | Volume | 131 |
| Issue | 3 | Pages | 340-9 |
| PubMed ID | 20518824 | Mgi Jnum | J:167106 |
| Mgi Id | MGI:4867159 | Doi | 10.1111/j.1365-2567.2010.03305.x |
| Citation | Raveney BJ, et al. (2010) TNFR1 signalling is a critical checkpoint for developing macrophages that control of T-cell proliferation. Immunology 131(3):340-9 |
| abstractText | Macrophages (Mvarphi) are professional antigen-presenting cells, but when they accumulate at sites of inflammation, they can inhibit T-cell proliferation. In experimental autoimmune uveoretinitis, this limits the expansion of T cells within the target organ. To define requirements for the elaboration of this outcome, we have generated populations of Mvarphi in vitro that could also regulate T-cell responses; stimulating CD4(+) T-cell activation and cytokine production, but simultaneously suppressing T-cell proliferation. When T cells are removed from the influence of such cells, normal T-cell responses are restored. We show that tumour necrosis factor 1 (TNFR1) signalling is a critical checkpoint in the development of such Mvarphi, as TNFR1(-/-) Mvarphi are unable to suppress T-cell proliferation. This deficit in antigen-presenting cells results in a lack of production of prostaglandin E(2) (PGE(2)) and nitric oxide, which are critical effector mechanisms that inhibit T-cell division. However, TNFR1 signalling is not required for the inhibitory function of Mvarphi because we could circumvent the requirement for this receptor, by maturing Mvarphi in the presence of exogenous interferon-gamma and PGE(2). This produced TNFR1(-/-) Mvarphi that inhibited T-cell proliferation and indicates that TNFR1 delivers a signal that is necessary for the development but not the execution of this function. |
